100P Characteristics and outcomes of patients (pts) with NTRK fusion-positive (NTRK+) metastatic / locally advanced (LA) solid tumours receiving non-TRK inhibitor (TRKi) standard of care (SoC), and prognostic value of NTRK fusions in clinical practice
| Autor: | Demetri, G.D. 1, Peters, S. 2, Hibbar, D.P. 3, Davies, J. 4, Maund, S.L. 5, Veronese, L. 6, Liu, H. 7, Humblet, O. 8, Perez, L. 9 |
|---|---|
| Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S399-S399 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|